JENNIFER WILLE: Open Payments
NPI 1811546229 · ROCHESTER HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$849 in 36 payments from 10 companies in 2025. Trend: 2023 $159 · 2024 $1,108 · 2025 $849
Food & beverage: $849
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $314 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $175 |
| Janssen Biotech, Inc. | 4 | $91 |
| PFIZER INC. | 4 | $87 |
| Lilly USA, LLC | 3 | $76 |
| RedHill Biopharma Inc. | 1 | $25 |
| QOL Medical, LLC | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Celltrion USA Inc. | 1 | $19 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
Products named: XIFAXAN, RINVOQ, LINZESS, TREMFYA, OMVOH, XELJANZ, VELSIPITY, Talicia.
Industry payments across MI — which companies pay providers there.
